resources
Webinar: Bridging the IVIVC Gap for Subcutaneous Biologics


Webinar
Preview - This content has been restricted to logged in users only.
Explore in-vitro models and predictive tools to assess subcutaneous bioavailability, improve IVIVC, and accelerate monoclonal antibody development.
Webinar
Predicting subcutaneous (SC) bioavailability of monoclonal antibodies presents unique challenges. This webinar explores emerging in-vitro tools, including the SCISSOR system and skin-on-chip models, alongside predictive modeling and cross-industry collaboration to improve in-vitro–in-vivo correlations (IVIVC), reduce clinical development risk, and accelerate the development of high-dose, high-volume subcutaneous biotherapeutics.
